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Hypercalcemic nephropathy: Chronic disease with predominant med.
ullary inner stripe injury. Because of the recently observed augmenta-
tion of medullary hypoxic injury by calcium in isolated perfused rat
kidneys (Kidney mt 34:186-194, 1988), renal morphology of chronic,
prolonged hypercalcemia was investigated in vivo. Rats were treated
with repeated injections of vitamin D2 (400,000 units/week) for two to
eight weeks. Chronic elevation of plasma calcium from 2.1 to 2.8
mmol/liter (P < 0.001) was associated by a fall in maximal urine
osmolality with no change in glomerular filtration rate. The most
significant morphological alterations occurred in the inner stripe of the
outer medulla; these changes were characterized by a sequence of
active injury with subsequent destruction and atrophy of the medullary
thick ascending limbs, fibroblastic and lymphocytic infiltration, and
secondary dilatation of collecting ducts. Similar changes occurred in the
medullary rays. These alterations were accompanied by increased renal
prostanoid production and a predisposition to acute kidney failure from
indomethacin. Because of its selective occurrence in zones of poorest
oxygen supply, this inner stripe injury may derive from vulnerability to
hypoxia and may play a role in some chronic nephropathies.
Calcium excess is toxic to cells in general [1, 2], and the
kidney is particularly susceptible to hypercalcemia. Increased
extracellular calcium induces kidney failure associated with
renal vasoconstriction, an ADH-resistant concentrating defect
and medullary nephrocalcinosis [31. Increased intracellular cal-
cium appears to play an important role in cell injury during the
pathogenesis of acute renal failure [4].
Over the past several years, studies in isolated perfused rat
kidneys have shown that the medullary thick ascending limbs
(mTAL) may be selectively vulnerable to hypoxic injury [5, 61.
Recently, we observed in isolated kidneys that calcium excess
adversely interacts with medullary hypoxia to increase mTAL
damage in zones of lowest oxygen supply [71. Decreasing
oxygen demand by tubules prevented calcium-induced damage
[7]. We concluded that calcium excess appears to increase the
susceptibility of the renal medulla to hypoxia by a mechanism
potentially operative in hypercalcemic nephropathy [71.
The present study was designed to test whether these obser-
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vations in vitro would be relevant to intact kidneys and whether
medullary hypoxia may predispose to mTAL injury in vivo. An
attempt was made to correlate functional and structural changes
in a model of chronic renal disease induced by prolonged
hypercalcemia. Since enhanced prostanoid production was
observed as well as progressive structural damage to renal
medulla (an important source of prostaglandins), the effects of
indomethacin upon renal function were studied during different
phases of the model.
Methods
Sprague-Dawley rats, weighing 290 to 490 g, fed on a stan-
dard Purina chow, were used for all experiments. Vitamin D2
(ergocalciferol) was injected subcutaneously at the average
dose of 400,000 units/week/rat for two to eight weeks to induce
chronic hypercalcemia (N = 44). Control animals were un-
treated rats (N = 36). In a small additional group (N = 4), an
attempt was made to prevent vitamin D2-induced hypercalce-
mia and renal morphological changes by prior parathyroidec-
tomy performed under ether anesthesia as in previous work [8],
followed by repeated injections of vitamin D2 as described
above, for a total of 25 days.
Renal function
Plasma total calcium, maximal urine osmolality (Usm) (after
24 hours dehydration), and creatinine clearance (using 24 hours
urine collection in Nalgene metabolic cages) were determined at
periodic intervals (two to three weeks).
The response of renal function to indomethacin was deter-
mined in two different ways. In a limited study, since previous
work has shown that a single injection of indomethacin does not
affect renal function after seven days of hypercalcemia [9, 10],
plasma creatinine before and 24 hours after indomethacin (10
mg/kg, i.v.) was determined in rats with a variable duration of
hypercalcemia (0 to 4 weeks, N = 20). Indomethacin obtained
from Sigma (St. Louis, Missouri, USA) was dissolved in
phosphate buffer (pH 8.0) and stored refrigerated up to two
weeks. Because it became apparent that indomethacin induced
a significant rise in plasma creatinine after four weeks of
hypercalcemia, inulin clearance was measured in additional rats
with either no hypercalcemia (controls, N = 6) or long standing
hypercalcemia (4 to 8 weeks, N = 6). After anesthesia with
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mactin (100 mg/kg body weight; Byk, Gulden Konstans, FRG)
cannulations of the trachea, urinary bladder, femoral artery and
vein were performed as previously reported [8]. 3H-inulin was
infused in normal saline at a rate of 2 mI/hr. After an equilibra-
tion period of 90 minutes and after two control collection
periods of 30 minutes each, indomethacin (5 mg/kg) was admin-
istered intravenously; half an hour later, two additional collec-
tion periods of 30 minutes each were obtained.
Renal morphology
The morphology of all kidneys was examined at variable
duration of hypercalcemia: two weeks (N = 16); four weeks (N
= 12); six weeks (N = 5); eight weeks (N = 5). Controls (N =
22), obtained from untreated rats maintained under similar
conditions for variable periods up to eight weeks, were pooled
as a single group, because morphology was uniformly normal.
After anesthesia with mactin, the right kidney was perfused-
fixed with 1.25% glutaraldehyde in 0.1 M phosphate buffer (pH
7.4) as previously described. A single coronal section was taken
through the center of the kidney to include the cortex, medulla
and papilla. These were further subdivided into four blocks.
The sections were postfixed in buffered 2% 0504, dehydrated,
and embedded in an araldite-Epon mixture. One-micron sec-
tions were cut and stained with 1% methylene blue. Thus, the
cortex and medulla at a similar level were examined. The
cytoarchitecture was initially surveyed at lower power. With
sufficient experience, low and medium power is sufficient to
focus on any abnormal zones which, of course, would be
examined at 40x or, on occasion, at lOOx if necessary. In the
cortex, the medullary rays were abnormal and could be easily
defined by their perpendicular orientation. The other zone of
pathological alteration—the inner stripe of the outer medulla—
could immediately be appreciated at lower power, in terms of
abnormalities, by the widening of the interstitial zone in asso-
ciation with apparent deletion of the mTAL. Some kidneys
were sliced transversely so that such changes could be seen in
horizontal sections. We had been able to do this at a fairly
consistent level in the inner stripe of the outer medulla, as
determined by percentage of vasa recta component (unpub-
lished results). The sections were examined by light micros-
copy, and the analysis of injury was completed in a blinded
fashion. Electron microscopic studies were basically done at 2
(N,l) and 4 (N,3) weeks with two controls. A total of six
animals were analyzed. Each had approximately six blocks
examined by light microscopy for area selection. Two to three
blocks from each animal were studied by electron microscopy.
Determination of prostanoids
Urine measurements. Prostaglandin E, (PGE2), 6-keto
PGFI,, the stable metabolite of prostacyclin (PGI2), and throm-
boxane B2 (TXB2), the stable metabolite of thromboxane A1,
were measured in 24-hour urine collections repeatedly obtained
from nine rats at different duration of hypercalcemia (baseline,
two weeks, four weeks). Urine extraction and determination of
prostanoids by radioimmunoassay was performed as previously
described [11, 121. Urine samples were submitted to extraction
and silicic acid chromatography before radioimmunoassays.
Urines were acidified to pH 3.5 with formic acid and extracted
twice with chloroform (1/3). The chloroform was removed by
evaporation at 37°C. Silicic acid chromatography was per-
formed by using the technique described in detail by Bertani et
al [13].
Tissue measurements; preparation of isolated glomeruli,
cortical tubules and medullary slices. The production of PGE2,
6-keto PGF1, and TXB2 by isolated glomeruli, cortical tubular
suspensions, and medullary and papillary slices was also mea-
sured in kidneys obtained from five hypercalcemic rats (at six
weeks) and eight control rats as previously described [11, 12].
After anesthesia with mactin and laparotomy, the kidneys were
rapidly removed and dissected to cortex, red medulla, and
papilla. The cortex was dissected and minced to a paste-like
consistency and pushed through 180 , 106 t, and 75 sieves.
Isolated glomeruli recovered from the 75 sieve were resus-
pended in cold tris(hydroxymethyl)aminomethane (Tris) HCI
buffer, pH 7.4, containing NaCI 135 mmol/liter, KCI 10 mmoll
liter. Na acetate 10 mmol/liter and glucose 5 mmol/liter, and
centrifuged twice at 120 x g for 90 seconds. Supernates were
discarded and the pellets resuspended in the same buffer. These
suspensions, examined by light microscopy, contain more than
90% isolated glomeruli. Isolated cortical tubules, recovered
from the 180 JL sieve, were resuspended in Tris-HC1 buffer and
centrifuged as described above. On light microscopy, these
suspensions contain 70 to 80% of intact proximal and distal
tubular fragments. After the last centrifugation, the supernatant
from glomerular and cortical tubular preparations was dis-
carded and the pellet resuspended in the same buffer supple-
mented with CaCI2 (5 mmol/liter). These suspensions were
incubated (in duplicate) without shaking at 37°C for 40 minutes,
and the incubation stopped by immersion of tubes in ice-cold
water. The tubes were then centrifuged for 10 minutes at 3000 g
at 4°C and the supernatants stored at —70°C until radioimmu-
noassay (RIA) determinations. The red outer medulla and the
cone-shaped white papilla protruding into the pelvis (inner
medulla) were cut into 8 to 10 slices and suspended in Tris-HCI
buffer. Inner and outer medullary slices were incubated (in
duplicate), after addition of CaCI2 (5 mmol/liter), without shak-
ing at 37°C for 40 minutes, before the incubation was stopped
and the tubes centrifuged as described above.
Prostaglandins were measured in the unextracted superna-
tants as previously described [11, 121. (3H)6-Keto PGF1 (120 to
180 Ci/mmol), (3H)PGE2 (30 to 50 Cilmmol), and (3H)TXB2
(>120 Ci/mmol) were from Amersham (UK). Antisera for PGE2
and TXB2 were from the Institut Pasteur, Paris, and that for
6-keto PGF1 from the laboratory of Professor L. Levine,
Brandeis University, Waltham, Massachusetts [12]. Protein
content of the preparations was measured by the method of
Lowry et al [14] and results expressed as pg or ng prostanoid
produced per mg protein in 30 minutes.
Statistical analysis
Results are presented as mean SE. Student's paired t-test,
analysis of variance, and correlations were performed using the
statistical package CRUNCH (Crunch Software Corporation,
Oakland, California, USA).
Results
Table 1 summarizes the effect of vitamin D, upon plasma
calcium, maximal Usm, and creatinine clearance at baseline
and after treatment. As expected, plasma calcium rose signifi-
cantly and remained elevated throughout the experiment. As
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Table 1. Effects of chronic vitamin D2 treatment upon plasma calcium, urine-concentrating ability, creatinine clearance, and urinary sodium
excretion (in parentheses is the number of experiments)
Baseline At two-three weeks At four-six weeks
Plasma calcium
mmo!/liter 2.06 0.03 (21) 2.84 0.08 (l7) 2.84 0.15 (l7)
Maximal U0
mOsm/liter 2,593 65 (14) 1,839 150 (l0) 1,519 238 (ll)
Creatinine clearance
ml/min/100 g body wi 0.4 0.04 (27) 0.4 0.04 (16) 0.4 0.05 (9)
Urinary sodium excretion
p.Eq/24 hrs 460 89 (22) 674 177 (15) 314 122 (9)
a P < 0.001 vs. baseline (ANOVA)
previously observed [9, 10], maximal Uosm was diminished in
association with the hypercalcemia, while the creatinine clear-
ance remained unchanged.
Morphological examination of the kidneys disclosed the most
significant alterations to be in the inner stripe of the outer
medulla in rats with chronic hypercalcemia. By light micros-
copy, medullary interstitial tissue was increased with prolifer-
ation of interstitial cells at the expense of normal tubular mass
(Figs. 1—3). Medullary thick ascending limbs (mTALs) showed
various degrees of collapse and atrophy associated with basal
lamina calcification and focal cell necrosis (Figs. 1—3). Alizarin
red S (2%, pH 5.5) staining in material not postfixed with
osmium tetroxide confirmed the calcification identified by light
and electron microscopy.
In Figure 1, the marked expansion of the interstitial area can
be seen with the concomitant diminution of mTAL cellular
mass. Although the tubular changes were those of atrophy and
obliteration, the latter best documented by electron micros-
copy, active necrosis could be focally identified (Fig. 2). The
mTAL destructive process was largely restricted to central
interbundle zones (Fig. 3A), where dilated collecting ducts
could also be observed (Fig. 3B and C). Fine structural studies
revealed necrotic mTALs (Fig. 4) with calcified organdIes
Fig. 1. Inner stripe of the outer medulla. Loss of
medullary thick ascending limb (mTAL) is severe in
some areas (right center) and more moderate in others
(lateral aspects). The intact and open mTALs (*), which
border the vasa recta, are those of the long-looped
nephrons. x50.
Fig. 2. inner stripe of the outer medulla. The mTALs
show focally a process of active destruction with cell
fragmentation () as opposed to the general chronic
changes which can be noted in previous and subsequent
figures. x430.
(mitochondria) and basal lamina. Such tubules could be identi-
fied by the numerous calcified mitochondria (Fig. 5). Their
content of collagen and fibroblasts (Figs. 4, 5) constituted
evidence of previous rupture. Atrophic tubules were numerous
(Fig. 4). Figure 6 shows the expanded interstitium to contain
accumulations of tubular remnants (cellular and basal lamina
fragments with calcification), increased collagen, histiocytes,
lymphocytes, and immature fibroblasts. Thus, there appeared
to be an active process of mTAL necrosis with rupture and
calcification, leading to atrophy of the remaining nephron
portion. This process may have involved other nephron seg-
ments such as thin limbs, but this was less easily defined. The
collecting ducts appeared better preserved but showed varying
degrees of dilatation and cystic change with more limited
associated fibrosis. Serial sections suggested that these collect-
ing duct alterations were the consequence of central interbundle
zone destruction with secondary tubular obstruction. All these
changes were progressive, confined to the inner stripe of the
outer medulla, and most prominent in the deepest zones of the
inner stripe and away from the vasa recta, that is, areas most
remote from oxygen supply.
In the renal cortex, rare focal tubular necrosis and calcifica-
tions were observed more frequently in hypercalcemic rats than
/I
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Fig. 3. Innerstripe of the outer medulla. Photograph A shows extensive loss of mTAL cellular mass primarily in the interbundle zones. Basal
lamina calcification (arrows) can be appreciated. The elements present in the interstitium can best be identified by electron microscopy (Figs. 4
& 6). Focally, collecting duct cystic change and dilatation (B & C) were striking and were apparently related to obstruction by the obliterative
central interbundle process. x200, x 180, x260.
in controls. The most consistent finding, however, was the
prominence of the medullary rays with tubular cystic changes,
deletion of cellular mass, and fibrosis (Fig. 7). The cystic
changes appeared to originate from the cortical collecting ducts,
but because of the simplification of the lining cells, it was
impossible to be certain that all of the cysts were of collecting
duct origin. The renal papilla was essentially unremarkable.
Figure 8 summarizes the effect of chronic vitamin D2 treat-
ment upon renal morphological alterations in the inner stripe
and in the medullary rays, using blinded semi-quantitation with
an arbitrary scale (0 to 4+): 1 + = very mild focal increase of the
interstitial zone accompanied by tubular atrophy; 2 + larger
numbers of atrophic tubules noted, associated with basal lamina
calcification; 3 + fairly extensive obliteration of central
interbundle zone, associated with marked widening of the
interstitium with often blatant calcification; 4+ = virtual oblit-
eration of central interbundle zone. As was noted earlier, cystic
changes appeared to be a reflection of the latter and was an
inevitable accompaniment of the higher degrees of pathological
alterations. The changes were strikingly more frequent in
hypercalcemic animals than in controls and were significantly
more obvious at four to eight weeks than at two weeks of
treatment. The changes were correlated with the number of
vitamin D2 injections the animal had received (inner stripe, r =
0.6, P < 0.001; medullary rays, r = 0.5, P < 0.01).
In parathyroidectomized rats, as expected, plasma calcium
before treatment with vitamin D2 was 1.7 0.1 mmol/liter (vs.
2.1 0.03 in intact rats, P < 0.001). At the end of a month of
treatment with vitamin D2, plasma calcium was 1.9 0.3
mmol/liter (significantly lower than 2.8 0.1 in non-parathy-
roidectomized animals treated with vitamin D2, P < 0.005).
Renal morphological alterations to the inner stripe were signif-
icantly reduced in this group, to an average score of 0.6 0.2
(vs. 2.2 0.3 in non-parathyroidectomized vitamin D-treated
rats, P <0.01), suggesting partial protection from vitamin D2 by
prevention of hypercalcemia.
The response of renal function to indomethacin appeared to
depend on the chronicity of vitamin D2 treatment. As shown in
Table 2, screening for renal failure after indomethacin (by
measuring plasma creatinine) suggested that prolonged hyper-
calcemia (four weeks) was necessary to predispose to indometh-
acm-induced renal dysfunction. The incremental rise in plasma
creatinine after indomethacin appeared to be significantly cor-
related with inner stripe morphological injury (r = 0.7, P <
0.001, N = 20). As measured by inulin clearance, indomethacin
produced a marked fall in the glomerular filtration rate in rats
treated for six weeks with vitamin D2 (Fig. 9).
Because of these findings, prostanoid production was exam-
ined in urine and kidneys of rats with hypercalcemia. Tables 3
and 4 describe the effects of chronic hypercalcemia upon renal
prostanoid production. As shown in Table 3, the main finding in
the urine was that, with prolonged hypercalcemia, 6-keto
-
I I..
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Fig. 4. A necrotic and calc(fled mTAL is noted
in the upper left. Its thickened basal lamina
extends (arrows) into the interstitial tissue,
partially defining a zone which once was an
intact mTAL. Within this area is an atrophic
tubule containing cast material. Intact thin limbs
(T) and a mTAL (*) can also be identified.
x3,700.
Fig. 5. This high power electron micrograph of
the central portion of a tubule, as noted in
Figure 4, shows calc jfled mitochondria adjacent
to collagen fibers. x27,000.
PGF1,r, excretion became significantly elevated compared to
baseline. Table 4 shows that prostanoid production, especially
6-keto PGF1, and TXB2, was increased in cortical tubules and
red medulla obtained from rats with chronic hypercalcemia
compared to controls. Prostanoid production by isolated gb-
meruli and papilla was unchanged.
Discussion
The response to calcium ion excess has attracted consider-
able attention, as it may play an important role in the patho-
genesis of both acute [41 and chronic renal failure [15]. Since
calcium accumulation could be a consequence rather than a
cause of cell damage in models of renal failure associated with
tubular necrosis, study of the effect of acute and chronic
hypercalcemia upon intact kidneys may be useful to understand
the interaction between calcium and renal injury. The kidney is
a prominent target of injury during acute or chronic hypercal-
cemia [3]. Moderate hypercalcemia frequently induces polyuria
or even renal failure before significant neuromuscular or cardiac
toxicity [31. Although calcium is well-recognized as a mediator
of cell injury in general [1, 2], the relative vulnerability of the
kidney to hypercalcemia, compared with that of other organs,
remains poorly understood.
Since calcium excess produces renal vasoconstriction, kid-
ney tissue could become ischemic during hypercalcemic
nephropathy; if this were the case, it is likely that the renal
medulla would be especially at risk because of its precarious
equilibrium between oxygen delivery and consumption [6].
Interestingly, the renal medulla appears to be particularly
susceptible to calcium toxicity. A defect in the ability to
concentrate urine is one of the earliest and most consistent
functional impairments during hypercalcemia in both clinical [3]
and experimental [16, 17] conditions. Medullary lesions have
been reported in animal models of hypercalcemia [16, 17] and in
human hypercalcemia [181. It seems reasonable to hypothesize,
therefore, that hypercalcemia might interact with hypoxia to
produce predominant injury to the renal medulla.
In isolated rat kidneys perfused without an oxygen carrier,
medullary hypoxia is consistently expressed by selective injury
to mTAL [5]. In a recent study, we observed that increasing
calcium in the perfusate of isolated kidneys augmented hypoxic
mTAL injury in the zones of lowest oxygen supply in a way that
was preventable by decreasing tubular oxygen demand [7]. The
adverse interaction between calcium excess and tubular injury
was confined to the inner stripe of the outer medulla, suggesting
a synergism between calcium and medullary hypoxia. The
present study was designed to test the relevance of these
observations in vitro to intact kidneys in vivo.
Chronic hypercalcemia was induced in rats by repeated
injections of vitamin D2 and was maintained for two to eight
weeks. The duration of treatment was purposely prolonged,
compared to reported studies [9, 10, 16, 17, 19, 20], to enhance
i;<!
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Fig. 6. This portion of the interstitiu,n Contains multiple
arrays of lamina densa material (arrows) as well as
immature fibroblasts (F) and a histiocyte (H). x7,900.
Fig. 7. This low power photograph of the, cortex shows
multiple medullary rays with extensive tubular atrophy.
cystic change, and fibrosis. x 18.
A
2.8
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Fig. 8. Semi-quantitative analysis of renal injury associated with
chronic vitamin D treatment. Statistical analysis was performed by
ANOVA and Scheffe's test for multiple comparisons. A. *P < 0.001 vs.
controls; **P < 0.01 vs. 2 weeks. B. *p <0.001 vs. controls; **p <0.05
vs. 2 weeks.
the likelihood of observing structural changes. As previously
described [9, 10, 16, 17, 19, 20], the earliest and most prominent
functional impairment from hypercalcemia affected the renal
concentrating mechanism (Table 1), suggesting that renal dam-
age may preferentially occur in the renal medulla.
Table 2. Effects of indomethacin and vitamin D2 combination
treatments upon plasma creatinine
Insults
Plasma creatmine p.mol/liter
Baseline After insult(s)
Indomethacin alone
N—S 99.8±7.5 84.8±6.9
Vitamin D2 alone
2—8 weeks, N = 26 61.7 2.1 75.5 4.2
Vitamin D2 (2 weeks)
+ indomethacin, N = II 84.4 4.5 113.6 15.0
Vitamin D2 (4 weeks)
+ indomethacin, N = 7 67.0 5.4 172.0 22.4
The new important finding of the present study was the
discovery of a distinct, selective, chronic and progressive
tubulo-interstitial injury to the inner stripe of the outer medulla.
This injury was characterized by destruction of mTAL, most
obvious in the central interbundle zones, away from the vasa
recta, and in the deepest areas of the outer medulla, most
remote from oxygen supply (Figs. 1—3). The distribution of this
injury is thus remarkably similar to that of hypoxic mTAL
damage observed during isolated kidney perfusion [5] in that it
follows putative gradients of medullary tissue oxygenation [5,
6]. This characteristic distribution was also seen in a recent in
vivo model of hypoxic mTAL damage resulting from combined
insults to the rat [21]. By analogy to the liver, this pattern of
*
**
a)
>-
ca
Co
a,
1.6
1.2
0.8
0.4
0.0
a p < 0.001 vs. baseline (paired t-test)
Controls 2 weeks 4-8 weeks
-
1 
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Table 3. Effects of chronic vitamin D2 treatment upon urinary
prostanoid excretion (N = 9 for all figures)
Baseline
At 2-3
weeks
At 4-6
weeks
Urinary 6-keto PGFIa
ng/day 9.3 1.0 14.3 1.3 16.2 3.Oa
Urinary PGE2
ng/day 204.8 61.5 201.3 28.8 203.1 47.1
Urinary TXB2
nglday 3.3 0.3 4.6 0.3 5.0 09b
a P < 0.05 vs. baseline (ANOVA)b0.05 <P < 0.1 vs. baseline (ANOVA)
0 30 60 90 120 150
Time, minutes
Fig. 9. Effect of indomethacin uponinulin clearance in rats with long
standing hypercalcemia. Control (O----O, N = 6) and hypercalcemic(S 5, vit D2, N = 6) rats had comparable body weights (419 28 g
vs. 417 38 g, P = NS). *P < 0.001, **P < 0.02 vs. controls.
damage in zones most remote from oxygen supply can be
paralleled to the centrilobular predisposition of hepatocytes to
hypoxic injury enhanced by toxins [22].
Study of these lesions by light and electron microscopy
showed a spectrum of mTAL morphology from normal tubules
near the vasa recta to most abnormal tubules around the
collecting ducts in the central interbundle zones. Injured mTAL
showed focal necrosis similar to hypoxic mTAL injury ob-
served during isolated perfusion of the rat kidney [5] and in vivo
after a combination of renal insults [21]. Other mTALs showed
collapse and various degrees of atrophy. The tubular mass was
replaced by an expanded interstitium with accumulation of
tubule remnants, collagen and mononuclear cells. Thus, a
process of mTAL necrosis and rupture appeared to have led to
atrophy of the remaining nephron portion and to replacement
by interstitial scar tissue. Because superficial, short-loop neph-
rons have their mTALs located in the central interbundle zone
[23], these nephrons may have been preferentially damaged,
while mTALs from long-loop tubules, ascending along the vasa
recta, would have been relatively preserved. It is conceivable
that hyperfiltration in these deep nephrons may have contrib-
uted to the relative preservation of overall kidney function.
In the renal cortex, focal tubular necrosis and calcification
were noted; this is in agreement with previous studies of
hypercalcemic models of shorter duration [16, 17, 24]. The most
prominent changes, however, involved the medullary rays,
where cystic tubular change, deletion of cellular mass, and
increase in interstitial tissue were observed. The cause for the
predominance of medullary ray injury is unclear but may relate
to regional hypoxia. The base of the medullary rays receives its
oxygen supply from the venous effluent of the ascending vasa
recta and can be predisposed to hypoxic injury [25]. Alterna-
tively, the cortical thick ascending limbs, which constitute a
substantial proportion of the tubules in the medullary rays,
originate from the short-loop nephrons and may have been
damaged in the inner stripe.
The inner medulla and the papilla were unremarkable. Spe-
cifically, no increase in interstitium was apparent even in zones
adjacent to grossly abnormal inner stripe tissue. Degranulation
of interstitial cells has been previously observed, but these were
studies of acute hypercalcemia [26].
Chronic hypercalcemia appeared to predispose to acute renal
failure from indomethacin. A marked increase in plasma creat-
mine after a single injection of indomethacin occurred only in
rats with prolonged hypercalcemia of four weeks duration
(Table 2). Acute renal failure after indomethacin was confirmed
by an inulin clearance study (Fig. 9). Several studies in rats and
dogs with acute or short-term hypercalcemia of eight days or
less have indeed shown no significant fall in the glomerular
filtration rate from a single injection of indomethacin [9, 10, 19,
27]. In one study, three repeated injections of indomethacin
were in fact needed to observe a decline in the glomerular
filtration rate [20] which did not occur after the first injection
[10]. The present results are consistent with an increased
susceptibility to prostaglandin inhibition in prolonged hypercal-
cemia of several weeks duration. This susceptibility appeared
to correlate with the progression of inner stripe injury, also
associated with increased prostanoid synthesis.
As shown in Tables 3 and 4, chronic hypercalcemia was
associated with elevated production of 6-keto PGFIa and TXB2
at the levels of cortical and medullary structures without
significant changes in glomerular prostanoid synthesis. Similar
findings were found in urine collections. Since TXB2 is a potent
vasoconstrictor, increased thromboxane synthesis during hy-
percalcemia may play a role in hypercalcemic renal vasocon-
striction. In consequence, endothelial cells may enhance the
local production of the vasodilator PG!2 to counterbalance
hypercalcemic vasoconstriction. Inhibition of increased synthe-
sis of renal prostanoids might have modified this delicate
equilibrium, precipitating renal failure. Interestingly, a predom-
inant stimulatory effect of hypercalcemia on PGI2 (over PGE2)
was also recently observed in man [28]. One may speculate that
in chronic hypercalcemia, vasodilator prostanoids afford a
protective effect upon renal function.
Although control and vitamin D2-treated rats were not pair-
fed, and hypercalcemic animals had a transient weight loss
(during the first two weeks of treatment), salt depletion is
unlikely to have played a major role in the findings observed. As
shown in Table 1, urinary sodium excretion did not differ before
and after vitamin D2 treatment. Morphological examination of
kidneys obtained from five rats, maintained on salt-depleted
diets for several weeks (daily urinary sodium, 69 25 pEq),
disclosed no injury (blinded score 0 for both medullary rays and
inner stripe—data not shown). Moreover, salt depletion en-
E
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Table 4. Prostanoid production by different renal structures in chronic vitamin D2-induced hypercalcemia (6 weeks) compared to control rats
Isolated glomeruli Cortical tubules Red medulla Papilla
6-keto PGF1
Control 447 74 1,037 353 265 40 19,785 2,352
Hypercalcemic 356 127 3,035 659L 651 ll8C 20,241 5,192
PGE2
Control 2,515 504 2,017 362 692 109 51,401 9,826
Hypercalcemic 2,765 889 3,090 29l 1,225 502 39,081 7,705
TXB2
Control 721 155 678 90 52 7 2,636 426
Hypercalcemic 444 144 1,540 299C 148 33C 3,397 545
Units are pg/mg protein/30 minutes incubation.
a P < 0.05 vs. controlb P < 0.01 vs. control
P  0.002 vs. control
hances the production of glomerular and papillary PGE2 [12]
which was unchanged in the hypercalcemic rats (Table 4).
The characteristic distribution of the morphological lesions to
the inner stripe with selective occurrence in zones of poorest
oxygen supply, in close resemblance to hypoxic mTAL injury
in vitro and in vivo, suggests a possible role for medullary
hypoxia in the vulnerability of the kidney to hypercalcemia in
vivo. Although focal lesions along the distal tubule (including
the mTAL) have been mentioned in short-term hypercalcemia
[16, 17], studies of experimental long-term hypercalcemia are
not available. In a different rat model of chronic hypercalcemia
produced by magnesium depletion, Schneeberger and Morri-
son, using light and electron microscopy, also reported selec-
tive damage to inner stripe of the outer medulla, mostly to the
medullary thick ascending limbs [29]. The study concluded:
"The site of the renal calcification is difficult to explain" [29].
Of interest, animals fed sodium phosphate both acute and
chronically show distinctive mTAL injury, which is character-
ized by an initial phase of necrosis with subsequent deposition
of calcium phosphate [301. In patients with chronic hypercalce-
mia, nephrocalcinosis has been observed with predominant
calcifications of the outer medulla and medullary rays [18, 31].
Since calcium is concentrated in the medulla, it is conceivable
that, compared to cortical tubules, the mTALs were exposed to
higher ambient levels of calcium, leading to greater damage in
the deeper portions of these tubules. However, the observation
that damage was most severe in areas removed from vascular
supply suggests oxygen deficiency as an important factor as
well. It has been previously suggested that calcium excess may
uncouple mitochondrial respiration before more severe cellular
damage occurs [32]. Such an effect is expected to be more
rapidly lethal to hypoxic cells in the inner stripe than to
well-oxygenated cells in the renal cortex. It is also conceivable
that calcium-induced vasoconstriction, acting by potentiation of
angiotensin II hemodynamic effect [20], would augment medul-
lary hypoxia by disturbing the delicate balance of oxygen
supply and demand normally existing in the outer medulla, as
recently observed with angiotensin II [33]. The reported in-
crease in medullary blood flow [34] and the observed rise in
prostanoid production may represent adaptive mechanisms that
ultimately fail to prevent medullary hypoxic injury. Thus,
medullary hypoxia may intensify the injury produced by cal-
cium excess, and hypercalcemia may enhance medullary hy-
poxic damage in a variety of synergistic mechanisms between
calcium and hypoxia.
Additional contributing factors for mTAL vulnerability to
hypercalcemia may be considered. The mTAL is a major site of
calcium reabsorption. The flux of calcium transport in Henle's
loop is increased in hypercalcemia [35], possibly leading to
calcium cellular overload and injury. Of all nephron segments,
however, the glomerulus is exposed to the highest fluxes of
calcium by far [35] and was only rarely damaged in the present
model, evidence against calcium traffic as a single factor. High
calcium fluxes are nevertheless particularly likely to potentiate
cellular damage initiated by local hypoxia. In addition, the
peritubular microenvironment of the outer medullary collecting
ducts may be relatively alkaline (due to proton secretion into
the urine), facilitating the precipitation of calcium phosphate in
the interstitium.
Of special interest, using a rat model of chronic hypercalce-
mia induced by vitamin D [36], Berl has recently reported a
selective impairment of the responsiveness of microdissected
mTALs to vasopressin with reduced adenylate cyclase activity,
while collecting ducts were preserved. The experiments were
performed after a week of vitamin D treatment. It is conceiv-
able that these functional changes reflect the earliest phases of
mTAL injury in chronic hypercalcemia to be followed only later
by overt morphological damage as observed in the present
study.
Interestingly, closely related tubulo-interstitial lesions con-
fined to the deepest portions of the outer medulla have been
reported in a variety of clinical and experimental conditions.
Focal calcifications surrounding collecting ducts in the inner
stripe ("mid-zone band"), associated with drop-out of short
loops of Henle and medullary fibrosis, have been often ob-
served in aging human kidneys and have been related to
ateriosclerosis [18, 37]. Nodular hyperplasia of medullary inter-
stitial cells has been proposed to originate from regional chronic
hypoxia [38]. Focal medullary calcified lesions in the inner
stripe have been reported in old cats [39]. More recently, a
model of cyclosporine toxicity in salt-depleted rats described a
generalized increase in interstitial cells most prominent in the
inner stripe of the outer medulla, associated with cyclosporine-
induced renal vasoconstriction [40, 41]. A feature common to
all these conditions is a chronic reduction in renal blood
perfusion which may adversely affect medullary oxygen bal-
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ance at a site most susceptible to hypoxic injury—namely, the
inner stripe of the outer medulla—because of the special
vulnerability of mTAL to hypoxia [6, 211. Inner stripe hypoxic
injury could, therefore, play a role in some chronic nephropa-
thies.
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